Optimization of 3-Cyano-7-cyclopropylamino-pyrazolopyrimidines Toward the Development of an In Vivo Chemical Probe for CSNK2
X. Yang, H. W. Ong, R. J. Dickmander, J. L. Smith, J. W. Brown, W. Tao, E. Chang, N. J. Moorman, A. D. Axtman, T. M. Willson
The paper develops analogs of SGC-CK2-1 to improve pharmacokinetic properties in mice by inhibiting GST and P450 enzymes through co-dosing protocols.
bioRxiv · May 15, 2023Pharmacology & Toxicology